Further investigations are required to figure out the potentials of PPARs and their coactivators as drug targets for cancer, which makes our study even more important in the contribution to the expression signature analysis of PPARA, PPARD, PPARG, PPARGC1A, and PPARGC1B. Here, PPARD is linked to cancer.